While this harsh environment is considered a hallmark of solid tumors, hematological malignancies such as lymphoma are similarly immunosuppressive, producing IL-10, TGFβ, and IL-13, among other inhibitory ligands that promote tumor growth and inhibit effector T-cells [14,15,16]. This evidence concerns the gene TGFB1 and neoplasm.